The Lupus Foundation of America, the national force devoted to solving the cruel mystery of lupus, announced the appointment ...

$48.7 billion for the National Institutes of Health (NIH), a $400 million increase for the largest source of lupus research funding in the world. The bill also provides a $30 million increase in ...

Experts aren’t sure exactly what causes lupus — a long-term disease that causes inflammation and pain in the body. But we know that having certain risk factors — characteristics that raise your ...

The Gary S. Gilkeson Career Development Award was designed for fellows and clinicians with the goal of supporting early career scientists and providing mentorship during a critical time in their lupus ...

The Lupus Foundation of America (LFA) and Lupus Canada are pleased to announce Mohamed Osman, MD, PhD, Associate Professor of ...

A new study found an association between hydroxychloroquine (HCQ) use and early and long-term benefits on kidney function in ...

A recent dual-cohort study has found that Lupus Low Disease Activity State (LLDAS) is an attainable and effective treatment target for people with lupus nephritis (LN, lupus-related kidney disease).

We answer some of the most common questions we receive about Saphnelo, the therapy for systemic lupus erythematosus.

Watch the recording of our webinar on CAR T cell therapies to hear from medical experts and lupus warriors who have participated in CAR T clinical trials.

New study reviewing the current scientific evidence on the safety and efficacy of stem cell therapy to treat rheumatic disease highlights the potential benefits of mesenchymal stromal cells for the ...

Read the details on how the Lupus Foundation of America estimates that 1.5 million Americans have lupus.

Executive Summary A recent survey was conducted for the Lupus Foundation of America by Qualtrics to explore American adults’ awareness and knowledge of lupus. 1,072 online respondents participated in ...